Contact Information
Company Information
Professional Summary
Nikolaj Skak serves as Chief Technology Officer at Biograil™. Biograil™ operates in the pharmaceuticals sector with approximately 28.0 employees. The company is headquartered in Rungsted, Capital Region of Denmark. To date, Biograil™ has raised 3327211.0 in total funding, with the most recent round being Seed.
Industry & Role Insights
-
•
MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
-
•
947 executive contacts are available in Capital Region of Denmark.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Outlook
Microsoft Office 365
YouTube
Bootstrap Framework
WordPress.org
Mobile Friendly
Keywords
pharmaceuticals
medical device
injection molding
biologics
oral delivery
technology
innovation
pharmaceutical manufacturing
biondd
oral drug delivery
injectable alternatives
capsule technology
biotechnology
pharmaceutical innovations
patient-centric solutions
drug administration
transforming healthcare
easy-to-swallow capsules
systemic drug delivery
improved treatment adherence
biocompatible devices
manufacturing technology
clinical trials
pharmaceutical development
strategic partnerships
biological therapies
healthcare transformation
oral ingestion
preclinical research
fda compliance
sustainable drugs
patient comfort
medication adherence
therapeutic areas
large patient populations
reinventing pharmaceuticals
scientific advisory board
investor partnerships
biotech startups
medical device technology
pharmaceutical research
biologics delivery systems
treatment outcomes
pharmaceutical performance
life sciences innovation
drug delivery solutions
effective medications
manufacturing scalability
drug compliance
health & well-being
automated drug delivery
medical
hospital & health care
health care
health
wellness & fitness
Related Executives
Outreach Guidance — pharmaceuticals Sector
Executives like Nikolaj Skak in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Biograil™.
Nikolaj Skak's Position in the MessageCEO Database
- •Nikolaj Skak is 1 of 1 verified executive contact we track at Biograil™.
- •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
- •942 verified executive contacts in Capital Region of Denmark are in the database.
- •9 verified contacts work at pharmaceuticals companies in the 28.0 employee range (same size as Biograil™).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.
Frequently Asked Questions
How do I reach Nikolaj Skak directly?
Nikolaj Skak's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Biograil™. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Nikolaj Skak work for?
Nikolaj Skak is Chief Technology Officer at Biograil™, a company in the pharmaceuticals sector with 28.0 employees. The company is based in Rungsted, Capital Region of Denmark.
Can I pitch or sell to Nikolaj Skak?
As Chief Technology Officer at Biograil™, Nikolaj Skak is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Nikolaj Skak directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Nikolaj Skak in?
Nikolaj Skak works in the pharmaceuticals industry as Chief Technology Officer at Biograil™. MessageCEO provides verified contact information for executives across all major industries.
Is Nikolaj Skak's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Nikolaj Skak's profile is kept up-to-date with the latest available information.
Last updated: June 26, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans